Skip to main content

Table 2 Tumor histologies and locations of the biopsies obtained for microarray analysis of the patients in the training set

From: A novel genomic signature predicting FDG uptake in diverse metastatic tumors

Histology Total (n = 71) Percentage (%)
Colorectal cancer 9.0 12.7
Breast cancer 8.0 11.3
Soft tissue sarcoma 7.0 9.9
Genitourinary tumor 7.0 9.9
Ovarian cancer 7.0 9.9
Lung cancer 7.0 9.9
Pancreatic cancer 6.0 8.5
Head and neck cancer 5.0 7.0
Esophageal cancer 4.0 5.6
Thyroid cancer 2.0 2.8
Bile duct cancer 2.0 2.8
Carcinoma of unknown primary (CUP) 1.0 1.4
Gastric cancer 1.0 1.4
Lymphoma 1.0 1.4
Melanoma 1.0 1.4
Mesothelioma 1.0 1.4
Merkel cell carcinoma 1.0 1.4
Kidney cancer 1.0 1.4
Locations of biopsies Total (n = 71) Percentage (%)
Liver 25 35.2
Retroperitoneal 16 22.5
Lymphadenopathy 13 18.3
Head and neck mucosa 3 4.2
Skin 3 4.2
Pleural 3 4.2
Lung 3 4.2
Breast 2 2.8
Mediastinum 2 2.8
Pancreas 1 1.4